Plunkett Research Online: Catalyst Pharmaceutical Partners, Inc.

CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biopharmaceutical company.....

Catalyst Pharmaceutical Partners, Inc.
Ticker: CPRX
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 305 529-2522
Fax: 305 529-0933
Address: 355 Alhambra Circle
Suite 1250
Coral Gables, FL 33134 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Patrick McEnany CEO/Chairman of the Board/Co-Founder/Director/President
Alicia Grande CFO/Chief Accounting Officer/Treasurer/Vice President
See More
A biopharmaceutical company.....See More See More

Auditor: Grant Thornton LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: